Scott A.M. Chambers Ph.D.
Scott is senior counsel in the firm’s Intellectual Property and Litigation & Dispute Resolution practices, and a member of the Dietary Supplements team.
He concentrates his practice on all areas of patent law, including licensing, patent infringement and validity issues, patent prosecution, patent term extensions under Hatch Waxman, client counseling, IP due diligence, and freedom to operate opinions. Scott is a skilled litigator who represents clients in federal courts and before government agencies, including the U.S. Patent and Trademark Oﬃce (USPTO), the Federal Trade Commission, and the International Trade Commission.
Having previously served as an associate solicitor for the USPTO, Scott’s knowledge of how the agency operates enables him to provide additional insight to clients involved in the patent process. Scott represents clients in inter partes review (IPR) proceedings and is an experienced appellate advocate before the Court of Appeals for the Federal Circuit. He clerked for former Judge Randall Rader.
Recognized as an authority in the area of patent law, he is a well-published author and a frequent speaker on the topic. He regularly serves as an expert witness on U.S. patent law and procedures. Scott currently teaches classes on international intellectual property law and advanced courses in patent law as an adjunct faculty member at Georgetown University Law School, Catholic University Law School, and George Washington Law School.
Scott has a Ph.D. in molecular biophysics. Before joining the USPTO and attending law school, he was a staff fellow at the National Institutes of Health.
Abbott Laboratories v. Novapharm, Ltd., 323 F.3d 1324 (Fed. Cir. 2003)
Benitec Australia Ltd. v. Nucleonics, Inc., 495 F.3d 1340 (Fed. Cir. 2007)
Emergency Fuel, LLC v. Pennzoil-Quaker State Co., 71 Fed. Appx. 826 (Fed. Cir. 2003)
Hoechst-Roussel Pharmaceuticals, Inc. v. Lehman, 109 F.3d 756 (Fed. Cir. 1997)
Honigsbaum v. Lehman, 903 F. Supp. 8 (D.D.C. 1995)
In re Alton, 76 F.3d 1168 (Fed. Cir. 1996)
In re Clement, 131 F.3d 1464 (Fed. Cir. 1997)
In re Dance, 160 F.3d 1339 (Fed. Cir. 1998)
In re Emert, 124 F.3d 1458 (Fed. Cir. 1997)
In re Mayne, 104 F.3d 1339 (Fed. Cir. 1997)
Merck & Co., Inc. v. Kessler, 80 F.3d 1543 (Fed. Cir. 1996)
Natural Alternatives International Inc. v. Creative Compounds LLC, 918 F.3d 1338 (Fed. Cir. 2019)
- Syracuse University, Maxwell School of Citizenship and Public Affairs, Certificate of Public Administration
- George Washington University, Juris Doctor
- Florida State University, Doctor of Philosophy
- Ohio State University, Bachelor of Science
- District of Columbia
- State of Virginia
- United States Patent and Trademark Office
- United States Court of Appeals, Federal Circuit
- Adjunct faculty, Georgetown University Law School; Catholic University Law School; George Washington Law School
- Biojudiciary Project
- Washington, D.C. Super Lawyers, 2007, 2009-18
- Virginia Super Lawyers, 2008-14
- Silver Medal Recipient, U.S. Department of Commerce, 1999
- Recognition Award, National Partnership for Reinventing Government, 1998
- Special Achievement and Gainsharing Awards, United States Patent and Trademark Oﬃce, 1989-92
- William Brinks Olds Hofer Gilson and Lione Scholarship, Excellence in Intellectual Property Law, 1992
- Distinguished Graduate, Patent Academy, 1990
- Senior Staff Fellow, National Institutes of Health, 1986-88
News & Insights
- NewsKevin Bell and Scott Chambers Quoted in a Legal Zoom Article Titled “What COVID-19 Vaccines Could Mean for Intellectual Property Rights”December 11, 2020 | In the News | LegalZoom
- NewsArnall Golden Gregory LLP Significantly Expands its Intellectual Property and FDA Expertise as Firm Continues Strategic Growth of its Washington, D.C. OfficeDecember 9, 2019 | In the News | Metro Atlanta CEO
- NewsAGG Significantly Expands its Intellectual Property and FDA ExpertiseNovember 18, 2019 | News Releases